CYCT1-4 Antibody
This CYCT1-4 Antibody is an unconjugated polyclonal product. It tagets CYCT1-4 using a a synthesized peptide derived from Escherichia coli O6:K15:H31 (strain 536 / UPEC) cdiA as the immunogen. This antibody is suitable for ELISA, WB. Purification: Antigen Affinity.
Product Specifications
Product Name Alternative
Cyclin-T1-4 (CycT1;4) (Protein AtCycT-like2) CYCT1-4 At4g19600 F24J7.161
UniProt
Q8GYM6
Reactivity
A. thaliana
Immunogen
Recombinant Arabidopsis thaliana CYCT1-4 protein
Target
CYCT1-4
Clonality
Polyclonal
Conjugation
Unconjugated
Purification
Antigen Affinity
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Applications Notes
1. Biorbyt guarantees the antibody purity > 95% confirmed by SDS-PAGE. 2. Biorbyt guarantees the antibody titer > 1: 64,000 confirmed by ELISA. 3. Biorbyt guarantees to offer antigen-specific Western Blot validation data. 4. Biorbyt guarantees 100% risk-free: No qualified antibody, no charge.
Tested Applications
ELISA, WB
Host or Source
Rabbit
Preservative
Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6292503-01 0.1 mL
DMRTA2, CT (DMRTA2, DMRT5, Doublesex-and mab-3-related transcription factor A2, Doublesex-and mab-3-related transcription factor 5) (MaxLight 405)
Sign In for Pricing
View Details MBS6292503-02 5x 0.1 mL
DMRTA2, CT (DMRTA2, DMRT5, Doublesex-and mab-3-related transcription factor A2, Doublesex-and mab-3-related transcription factor 5) (MaxLight 405)
Sign In for Pricing
View Details MBS6431202-01 0.1 mL
Peroxiredoxin 1 (PRDX1, PAG, PAGA, PAGB, PRX1, PRXI, MSP23, NKEFA, TDPX2, NKEF-A) (MaxLight 750)
Sign In for Pricing
View Details MBS6431202-02 5x 0.1 mL
Peroxiredoxin 1 (PRDX1, PAG, PAGA, PAGB, PRX1, PRXI, MSP23, NKEFA, TDPX2, NKEF-A) (MaxLight 750)
Sign In for Pricing
View Details 